Respiratory failure is a predictable cause of death in end stage lung disease including COPD and neuromuscular disorders, and the symptom burden for these individuals in the last six months of life is significant. Palliative care services are less well-developed for patients with chronic disorders compared to those with malignant disease; and communication problems can be compounded by a mismatch in expectadons between patients and health care providers on prognosis and other issues. Most patients want more information about their illness to facilitate participation in decision making. Noninvasive ventilation may extend life and palliate symptoms in neuromuscular disorders such as Duchenne muscular dystrophy and motor neurone disease/ALS.
Introduction
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide, being the fourth commonest cause of death in the USA and a leading cause of hospital admissions in Europe. Most patients die of respiratory failure, often during an infective exacerbation. Respiratory failure is the terminal event in many other conditions including interstitial lung disease and neuromuscular disorders involving the respiratory muscles. The management of the end stage of these disorders is often ad hoc and fragmented compared to organized palliative care programmes for individuals with cancer. A better outcome can be achieved by placing the focus on symptom relief, patient education about the chronic conditions, and involving patients and families in decision making.
COPD
While there has been a recent vigorous effort to identify individuals with early COPD by spirometry and treat Correspondence: Royal Brompton and Harefield NHS Trust, Sydney Street, London SW3 6NP, UK E-mail: a.simonds@rbh.nthames.nhs.uk this pharmacologically, advances in the management of end stage lung disease such as lung transplantation or lung volume reduction surgery are suitable only for a minority and carried out in even fewer. Where low cost interventions have been shown to be effective and widely applicablesuch as pulmonary rehabilitation and long term oxygen therapy, access to these is not universal as chronic disorders are often given low priority even in well-resourced health services.
The last six months of life in COPD patients has been examined by Lynn et al.' as part of a larger US-based SUPPORT project designed to assess patient preferences and decision making in severe disease. In a group of over 1000 COPD patients who died within six months of an index admission (average age 70 years), nearly 40% had more than three co-morbidities, and less than 10% rated their quality of life as very good or excellent. The symptom burden for these individuals was substantialthe majority experienced moderate or severe dyspnoea most or all of the time. Around 20-30% of patients had moderate or severe pain and a similar proportion reported depression or anxiety, these scores worsening further as patients approached death. Much attention has been devoted, quite properly, to the palliative care of individuals dying from lung cancer. It is instructive to compare and contrast end of Living and dying with respiratory failure: facilitating decision making Anita K Simonds 57 life experiences for individuals with lung cancer and COPD. Claessens et al. 2 have assessed the course of illness and patterns of care in cohorts with advanced COPD and stage III or IV non small cell lung cancer. The main outcome measures were symptoms, patients' preferences for resuscitation and ventilator use, and estimates of survival. Dyspnoea and pain were major problems for patients. Fifty-six per cent of COPD patients and 32% of lung cancer patients had severe dypsnoea, whereas 28% of patients with lung cancer and 21% of those with COPD had severe pain. Interestingly, patients with both conditions had similar preferences for the focus of care, and their wish to be resuscitated or receive mechanical ventilation. Sixty per cent in both groups expressed a wish for comfort care only. However, patients with COPD were much more likely to receive mechanical ventilation (34% of those with COPD and 4% with lung cancer), and cardiopulmonary resuscitation (10.7 versus 5.0%, respectively). In a UK study, Gore et al.3 have compared palliative care provision in 50 COPD patients with an FEVI < 750 mL (and at least one previous admission for respiratory failure) and 50 patients with unresectable non small cell lung cancer. The COPD group had significantly worse scores for health status (SF 36), and activities of daily living than the lung cancer group, and considerably higher levels of anxiety and depression. Furthermore, 82% of the COPD patients were housebound and 36% chair bound compared to figures of 36% and 10% for lung cancer patients, respectively. Despite these findings, 30% of lung cancer patients had access to palliative care services such as a Macmillan nurse or hospice support and an additional 56% were aware of these services or had been offered them, whereas none of the COPD group had been offered or received palliative care options.
One of the problems is estimating life expectancy in COPD patients. Not surprisingly studies show survival is better for COPD patients (six month survival, 67.8 versus 35.7%)2 but it is much more difficult to predict long term outlook in COPD. Consequently, the use of a cancer model to predict the need for palliative care is unhelpful, as the obvious and predictable decline in lung cancer is not mirrored by a similar disease trajectory in COPD. In the latter, most patients remain at a slowly deteriorating level of function until the unpredictable development of an acute exacerbation during which their prognosis may suddenly worsen. Lynn et al. 1 found that physicians were moderately good at estimating survival in COPD patients, but were most likely to underestimate prognosis at the more severe end of the COPD spectrum. Self-reported quality of life was correlated with survival, but patient estimates of their own survival did not correlate well with the actual outcome.
Neuromuscular disease
Respiratory physicians are often asked to advise on the end stage management of patients with neuromuscular disorders affecting the respiratory muscles, as the vast majority die of respiratory complications. It is important to stress that ventilatory failure is not necessarily a terminal event in patients with some forms of neuromuscular disease. For example, in patients with previous poliomyelitis, active treatment of ventilatory failure with noninvasive positive pressure ventilation (NIV) is strongly indicated as these individuals are likely to live to a normal life expectancy with the use of nocturnal ventilatory support.. . Similarly, in some congenital myopathies and muscular dystrophies, long term survival can be achieved with NIV, and many children now reach adulthood who previously would have died in childhood without receipt of ventilatory support. Many Duchenne muscular dystrophy patients are now living into their 30s and 40s following the introduction of NIV However, in some situations, ventilatory support can only be predominantly palliative. A case in point is motor neurone disease (amyotrophic lateral sclerosis) (MND/ALS). Several recent studies have shown that life expectancy is increased with the use of NW,6'7 in shown that NIV can improve quality of life in MND/ALS patients despite a continuing physical decline. NIV is however, more difficult to apply in individuals with severe bulbar insufficiency and here management becomes more problematical. Although placement of a tracheostomy is a possibility, in many families this imposes an added and difficult burden, and prolongs time in hospital while training of carers takes place. A combination of NIV and cough assist devices may be valuable in this situation, and for the short term use of a mini tracheostomy can be considered. It is notable that even where the outcome is predictable, as in ALS, one prospective study in the US'0 has shown that many patients were not offered or did not take up palliative care options, and only 18% had completed DNR orders in their medical charts.
What do patients want?
Research on the patient perspective on end of life care is mostly based on the experience of cancer patients in wmw.Rqcurrml.oom Living and dying with respiratory failure: facilitating decision making Anita K Simonds 58 hospice settings. There has been little systematic study of the wishes of people with nonmalignant conditions. It is clear, however, that what worries patients is a lack of autonomy over the circumstances of their dyingin particular, powerlessness over decisions about medical treatments, including those that prolong life. As
Clark"1 has pointed out, the fear of death is being replaced by the fear of dying.
With the recent directives that resuscitation (DNR) status should be discussed with patients on or soon after admission to hospital, individuals with severe lung disease are now faced with addressing this issue, possibly before they have formulated a view or even appreciated the severity of their condition, and at a time when emotional and physical reserves may be low. These decisions can be complexfor example, the use of NIV in infective exacerbations of COPD is a valuable option, but all concerned need to be clear whether NIV will be the ceiling of treatment or if intubation and conventional ventilation are indicated should NIV fail. While many patients welcome the opportunity to participate in decision making and transmit their views to the medical team and family, hurried end of the bed discussion can lead to distress and misunderstanding. In the author's experience individuals value the chance to discuss symptom management and how this is going to affect the rest of their life, rather than a complete focus on how they might diealthough the DNR decision is, necessarily, part of that discussion.
Gore et al. 3 found that over 40% of COPD patients wanted more information about their illness and future management, but the nature of the information required varied. Not all wanted highly detailed information and some suggested that vivid accounts of likely progression would be distressing. Forty-two per cent of lung cancer and 26% of end stage COPD patients reported or implied that they did not know whether they would die of their disease, and when questioned on why they did not seek more information from the medical team, many felt that this would be inappropriate and such discussion should be initiated by their specialists. Curtis et al. 12 carried out a study examining patient attitudes to physician skills in providing end of life care, and compared these in patients with COPD, AIDS and cancer. Common themes emergedwithin the COPD patients especially there was a strong desire for more information specifically on the course of the disease, treatment options, how these treatments work and their limitations. There was also a need to discuss what dying might be like and a desire to know more about advance directives. As in the UK study,3 there was a feeling that these discussions and explanations should be initiated by the doctor.
Chronic Repratory Disee
The patients with cancer emphasized a particular concern about maintaining hope, recognizing that, although the terminal nature of the condition needed to be confronted, hope could be redirected to quality of life and positive aspects of the here and now. This need to maintain hope is likely to be relevant to respiratory failure patients, too. As Steinhauser et al.1 have commented:
After a diagnosis, patients usually hope for a cure. However, they also hope for a lack of pain, lucidity, good quality of life and a physician who is committed to being with them throughout the care process.
Observations'3 from families, patients and health care providers on what constitutes a good death have thrown up some interesting differences in perspective. While health care providers emphasize almost exclusively physiological aspects such as providing sufficient pain and symptom relief, patients and families also characterized a 'bad death' as a lack of opportunity to plan ahead, arrange personal affairs, decrease family burden or say good bye. The authors listed the main components of a good death as: S S S S S S pain and symptom management; clear decision making; preparation for death; a sense of completion; contributing to others; and affirmation of the whole person. These considerations make it clear that patients require more from us in terms of: information about the course of their disease, its evolving management, why such treatments may be a value at some points in the natural history and not others, and how that individual will be supported both physically and emotionally throughout the course of their illness. It is equally evident that the amount of information needed will vary from patient to patient and family to family, and will change over time. As with much in medicine, this is a matter of clinical judgement. Respiratory physicians need to ensure that treatment opportunities such as pulmonary rehabilitation, long term oxygen therapy and NIV are not missed. Finally, Quill14 has defined a bad death as a medical emergency. There is certainly every reason for us to focus just as much on these aspects of end stage care as say, the pharmacology of adrenergic and cholinergic receptors in the lung. On a practical clinical basis, discussion should be actively raised with COPD and neuromuscular patients, so that information can be titrated over time. Pulmonary rehabilitation sessions as well as outpatient appointments provide a good opportunity for education, and Living and dying with respiratory failure: facilitating decision making Anita K Simonds 59 the outcome of these discussions should be recorded in the medical notes. Furthermore, daily handovers of inpatients should include discussion not only of those with acute illnesses, but also those receiving terminal care so that care plans can be reviewed and adapted to the needs of the patient and family.
